Comparison of the Performance of the Infiniti Vision and the Series 20000 Legacy Phacoemulsification Systems

This study has been completed.
Sponsor:
Information provided by:
Medical University of South Carolina
ClinicalTrials.gov Identifier:
NCT00366665
First received: August 17, 2006
Last updated: NA
Last verified: May 2005
History: No changes posted
  Purpose

To compare the efficiency of the Infiniti vision system and the Series 20000 Legacy System phacoemulsification units during routine cataract extraction.


Condition Intervention
Cataract Extraction
Device: Legacy 20000
Device: Infinit system

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double-Blind
Primary Purpose: Treatment
Official Title: Comparison of the Infiniti Vision and the Series 20000 Legacy Systems

Resource links provided by NLM:


Further study details as provided by Medical University of South Carolina:

Primary Outcome Measures:
  • Ultrasound time
  • Amount of fluid used
  • Post operative visual acuity.

Estimated Enrollment: 30
Study Start Date: March 2005
Estimated Study Completion Date: May 2005
  Eligibility

Ages Eligible for Study:   50 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Cataract
  • Eligible for cataract extraction with primary implantation of a posterior chamber IOL
  • 2 to 3+ cataract density

Exclusion Criteria:

  • Preoperative ocular pathology that can affect visual acuity
  • Corneal irregularities such as keratoconus, corneal dystrophy, corneal opacities.
  • Previous intraocular or corneal surgery.
  • Other ocular surgery at the time of the cataract extraction.
  • Surgical Exclusion Criteria:
  • Significant intraoperative intraocular bleeding
  • Detached Descemet’s membrane
  • Implantation of the intraocular lens in the anterior chamber or sulcus
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00366665

Sponsors and Collaborators
Medical University of South Carolina
Investigators
Principal Investigator: Kerry D. Solomon, MD Medical University of South Carolina
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00366665     History of Changes
Other Study ID Numbers: MRC-05-002
Study First Received: August 17, 2006
Last Updated: August 17, 2006
Health Authority: United States: Food and Drug Administration

ClinicalTrials.gov processed this record on September 16, 2014